Key facts
- It has raised $500K; the latest was Seed Round in Dec 2024.
- Notable investors include Y Combinator, Team Ignite Ventures, Teamworthy Group.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Chorrie
- ·The full record, as it builds
Funding rounds
No funding rounds for Chorrie are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Chorrie
Developer of an AI-powered no-code platform designed to automate medical billing teams' revenue cycle management. The company's platform offers to turn tedious manual claims checks into automated ones, allowing them to scale esoteric subject-matter expertise specific to an individual practice or team which integrates directly with native EMR systems, enabling clients with work optimization without workflow disruption.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2024
- Employees
- 3
- Website
- chorrie.com/
- Ownership
- Privately Held (backing)
Chorrie doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Chorrie shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Chorrie in its N-PORT filings yet. We sweep new filings monthly.